Corcept Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Trade Corcept Therapeutics 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About CORT
Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B.
CEOJoseph K. Belanoff
CEOJoseph K. Belanoff
Employees500
Employees500
HeadquartersRedwood City, California
HeadquartersRedwood City, California
Founded1998
Founded1998
Employees500
Employees500
CORT Key Statistics
Market cap7.79B
Market cap7.79B
Price-Earnings ratio63.55
Price-Earnings ratio63.55
Dividend yield—
Dividend yield—
Average volume2.05M
Average volume2.05M
High today$76.84
High today$76.84
Low today$71.78
Low today$71.78
Open price$73.60
Open price$73.60
Volume1.01M
Volume1.01M
52 Week high$117.33
52 Week high$117.33
52 Week low$29.42
52 Week low$29.42
CORT News
Simply Wall St 7h
Corcept Therapeutics (NasdaqCM:CORT) Dropped From Russell 2000 and Growth Indexrecently saw a decline in its share price by 1.43% over the last week. This price movement occurred against a backdrop of the company's removal from the Russell...
People also own
Based on the portfolios of people who own CORT. This list is generated using Robinhood data, and it’s not a recommendation.